AI in Clinical Trials Market: Accelerating Growth with Advanced Analytics The AI in Clinical Trials industry is transforming healthcare research by enhancing data accuracy and operational efficiency, driving significant business growth. With innovations in machine learning and predictive analytics, the market is witnessing rapid expansion propelled by increased adoption of AI-powered tools across clinical trial phases. Market Size and Overview The Global AI in Clinical Trials Market is estimated to be valued at USD 1.77 Billion in 2025 and is expected to reach USD 5.12 Billion by 2032, growing at a compound annual growth rate (CAGR) of 16.4% from 2025 to 2032. This substantial AI in Clinical Trials Market Growth stems from escalating demand for faster drug development and improved patient recruitment processes. Increasing investments in healthcare technology underline the market scope, while regulatory bodies worldwide are adapting frameworks conducive to AI integration, further accelerating market revenue potential. https://www.coherentmi.com/industry-reports/ai-in-clinical-trials-market